Laurent Peyrin-Biroulet

Laurent Peyrin-Biroulet

UNVERIFIED PROFILE

Are you Laurent Peyrin-Biroulet?   Register this Author

Register author
Laurent Peyrin-Biroulet

Laurent Peyrin-Biroulet

Publications by authors named "Laurent Peyrin-Biroulet"

Are you Laurent Peyrin-Biroulet?   Register this Author

100Publications

1286Reads

-Profile Views

The Selective Sphingosine 1-Phosphate Receptor Modulator Etrasimod Regulates Lymphocyte Trafficking and Alleviates Experimental Colitis.

J Pharmacol Exp Ther 2019 Jun 14;369(3):311-317. Epub 2019 Mar 14.

Beacon Discovery Inc., San Diego, California (H.A.-S., K.L.-B., C.C.); Crown Bioscience, Inc., San Diego, California (M.S.); Arena Pharmaceuticals, Inc., San Diego, California (H.K.K., J.A.); and Institut National de la Santé et de la Recherche Médicale U954 and Department of Gastroenterology, Nancy University Hospital, Lorraine University, Nancy, France (L.P.-B.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1124/jpet.118.254268DOI Listing
June 2019

Detection and management of early stage inflammatory bowel disease: an update for clinicians.

Expert Rev Gastroenterol Hepatol 2019 Jun 22;13(6):547-555. Epub 2019 Apr 22.

a IBD Center, Department of Gastroenterology , Humanitas Research Hospital , Rozzano, Milan , Italy.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/17474124.2019.1
Publisher Site
http://dx.doi.org/10.1080/17474124.2019.1605291DOI Listing
June 2019

Effectiveness of Infliximab Biosimilar in Crohn's Disease: A Dime, A Dozen.

Gastroenterology 2019 Jun 26;156(8):2349-2351. Epub 2019 Apr 26.

IBD Center, Department of Gastroenterology, Humanitas Clinical and Research Center, Rozzano and Department of Biomedical Sciences, Humanitas University, Rozzano, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2019.04.029DOI Listing
June 2019

Big data in IBD: a look into the future.

Nat Rev Gastroenterol Hepatol 2019 May;16(5):312-321

INSERM U954 and Department of Hepatogastroenterology, Nancy University Hospital, Université de Lorraine, Vandoeuvre-lès-Nancy, Nancy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41575-019-0102-5DOI Listing
May 2019

Vedolizumab for the treatment of inflammatory bowel diseases: from symptomatic control to mucosal healing.

Immunotherapy 2019 May 12;11(7):565-575. Epub 2019 Mar 12.

Department of Gastroenterology, IBD Center, Humanitas Clinical & Research Center, 20089, Milan, Italy.

View Article

Download full-text PDF

Source
https://www.futuremedicine.com/doi/10.2217/imt-2018-0209
Publisher Site
http://dx.doi.org/10.2217/imt-2018-0209DOI Listing
May 2019

Vedolizumab Treatment in Extra-Intestinal Manifestations in Inflammatory Bowel Disease: A Systematic Review.

J Crohns Colitis 2019 May 10. Epub 2019 May 10.

Department of Hepato-Gastroenterology and Inserm U954, University Hospital of Nancy, University of Lorraine, Vandoeuvre-lès-Nancy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ecco-jcc/jjz095DOI Listing
May 2019

Loss of Response to Vedolizumab and Ability of Dose Intensification to Restore Response in Patients With Crohn's Disease or Ulcerative Colitis: A Systematic Review and Meta-analysis.

Clin Gastroenterol Hepatol 2019 Apr 20;17(5):838-846.e2. Epub 2018 Jun 20.

Department of Biomedical Sciences, Humanitas University, Milan, Italy; IBD Center, Humanitas Clinical and Research Center, Milan, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2018.06.026DOI Listing
April 2019

Noninvasive Multimodal Methods to Differentiate Inflamed vs Fibrotic Strictures in Patients With Crohn's Disease.

Clin Gastroenterol Hepatol 2019 Apr 14. Epub 2019 Apr 14.

Inflammatory Bowel Disease Centre, Humanitas Clinical and Research Centre, Rozzano, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Rozzano, Milan, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2019.04.025DOI Listing
April 2019

Environmental Risk Factors for Inflammatory Bowel Diseases: an Umbrella Review of Meta-analyses.

Gastroenterology 2019 Apr 20. Epub 2019 Apr 20.

Department of Biomedical Sciences, Humanitas University, Milan, Italy; IBD Center, Humanitas Clinical and Research Center - IRCCS, Milan, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2019.04.016DOI Listing
April 2019

Combination Therapy With Vedolizumab and Tofacitinib in a Patient With Ulcerative Colitis and Spondyloarthropathy.

Clin Gastroenterol Hepatol 2019 Mar 13;17(4):794-796. Epub 2018 Aug 13.

Inserm U954, Department of Gastroenterology, Nancy University Hospital, Nancy, Université de Lorraine, France.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15423565183082
Publisher Site
http://dx.doi.org/10.1016/j.cgh.2018.08.017DOI Listing
March 2019

Effectiveness of golimumab in ulcerative colitis: A review of the real world evidence.

Dig Liver Dis 2019 03 16;51(3):327-334. Epub 2018 Nov 16.

INSERM U954 and Department of Hepatogastroenterology, Nancy University Hospital, University of Lorraine, Vandoeuvre-lès-Nancy, France. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15908658183122
Publisher Site
http://dx.doi.org/10.1016/j.dld.2018.11.002DOI Listing
March 2019

Anti-fibrotic drugs for Crohn's disease: Ready for prime time?

Curr Pharm Des 2019 Mar 7. Epub 2019 Mar 7.

IBD Centre, Humanitas Clinical and Research Centre, Rozzano, Milan. Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1381612825666190308100844DOI Listing
March 2019

Anti-adhesion molecules in IBD: does gut specifity really make the difference?

Curr Pharm Des 2019 Mar 7. Epub 2019 Mar 7.

IBD Centre, Humanitas Clinical and Research Centre, Rozzano, Milan. Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1381612825666190307165703DOI Listing
March 2019

Biosimilars of adalimumab in IBD: are we ready for that?

Curr Pharm Des 2019 Mar 11. Epub 2019 Mar 11.

IBD Center, Department of Gastroenterology, Humanitas Clinical and Research Institute, Rozzano, Milan. Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1381612825666190312113610DOI Listing
March 2019

A Treat-to-Target Update in Ulcerative Colitis: A Systematic Review.

Am J Gastroenterol 2019 Mar 22. Epub 2019 Mar 22.

Department of Hepato-Gastroenterology and Inserm U954, University Hospital of Nancy, University of Lorraine, Vandoeuvre-lès-Nancy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14309/ajg.0000000000000183DOI Listing
March 2019

Integrating Patient-Reported Outcomes Into Treat-to-Target Monitoring Algorithms.

Clin Gastroenterol Hepatol 2019 Feb 25;17(3):395-396. Epub 2018 Aug 25.

INSERM U954 and Department of Gastroenterology, Nancy University Hospital, Université de Lorraine, Vandoeuvre-lès-Nancy, France.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15423565183089
Publisher Site
http://dx.doi.org/10.1016/j.cgh.2018.08.060DOI Listing
February 2019

Efficacy and Safety of Induction Therapy With Calcineurin Inhibitors in Combination With Vedolizumab in Patients With Refractory Ulcerative Colitis.

Clin Gastroenterol Hepatol 2019 Feb 10;17(3):494-501. Epub 2018 Sep 10.

Service d'Hépato-gastro-entérologie, centre hospitalo-universitaire de Bordeaux, Hôpital Haut-Lévêque, Universite Bordeaux, Bordeaux, Pessac, France. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15423565183096
Publisher Site
http://dx.doi.org/10.1016/j.cgh.2018.08.081DOI Listing
February 2019

Dose de-escalation to adalimumab 40 mg every three weeks in patients with inflammatory bowel disease-A multicenter, retrospective, observational study.

Dig Liver Dis 2019 02 8;51(2):236-241. Epub 2018 Nov 8.

INSERM U954 and Department of Hepato-Gastroenterology, University Hospital of Nancy, Lorraine University, Vandoeuvre-lès-Nancy, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.dld.2018.10.022DOI Listing
February 2019

Bispecific antibodies: The next generation of targeted inflammatory bowel disease therapies.

Autoimmun Rev 2019 Feb 17;18(2):123-128. Epub 2018 Dec 17.

Eli Lilly Biotechnology Center, Eli Lilly and Co, San Diego, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.autrev.2018.07.014DOI Listing
February 2019

Timely Use of Biologics in Early Crohn's Disease: The Return of "Hit Hard and Early"?

Dig Dis Sci 2019 Feb 6. Epub 2019 Feb 6.

INSERM U954 and Department of Gastroenterology, Nancy University Hospital, Université de Lorraine, 1 Allée du Morvan, 54 511, Vandœuvre-lès-Nancy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10620-019-05504-xDOI Listing
February 2019

Impact of inflammatory bowel diseases on working life: A French nationwide survey.

Dig Liver Dis 2019 Feb 11. Epub 2019 Feb 11.

Department of Gastroenterology, Grand-Sud Polyclinic, Nîmes, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.dld.2019.01.024DOI Listing
February 2019

Early changes in the pharmacokinetic profile of vedolizumab-treated patients with IBD may predict response after dose optimisation.

Gut 2019 01 13;68(1):178-179. Epub 2018 Jan 13.

Department of Gastroenterology, Nancy University Hospital, Université de Lorraine, Vandœuvre-lès-Nancy, France.

View Article

Download full-text PDF

Source
http://gut.bmj.com/lookup/doi/10.1136/gutjnl-2017-315766
Publisher Site
http://dx.doi.org/10.1136/gutjnl-2017-315766DOI Listing
January 2019

Cost savings using a test-based de-escalation strategy for patients with Crohn's disease in remission on optimized infliximab: A discrete event model study.

Dig Liver Dis 2019 01 5;51(1):112-119. Epub 2018 Sep 5.

Inserm U954 and Department of Gastroenterology, Université de Lorraine, Nancy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.dld.2018.08.029DOI Listing
January 2019

Vaccination for influenza and pneumococcus in patients with gastrointestinal cancer or inflammatory bowel disease: A prospective cohort study of methods for improving coverage.

Aliment Pharmacol Ther 2019 Jan 28;49(1):84-90. Epub 2018 Nov 28.

Department of Gastroenterology and NGERE Unit, Inserm, University Hospital of Nancy, Lorraine University, Vandoeuvre-lès-Nancy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/apt.15057DOI Listing
January 2019

Biosimilars of adalimumab: the upcoming challenge in IBD.

Expert Opin Biol Ther 2019 Jan 2. Epub 2019 Jan 2.

a IBD Center, Department of Gastroenterology , Humanitas Clinical and Research Institute , Rozzano, Milan , Italy.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/14712598.2019.1
Publisher Site
http://dx.doi.org/10.1080/14712598.2019.1564033DOI Listing
January 2019

Personalised medicine in inflammatory bowel diseases: a patient survey.

Scand J Gastroenterol 2019 01 20;54(1):135. Epub 2019 Jan 20.

a Department of Gastroenterology , Nancy University Hospital, Lorraine University , Vandoeuvre-lès-Nancy , France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/00365521.2018.1555280DOI Listing
January 2019

Vedolizumab Trough Levels and Histological Healing During Maintenance Therapy in Ulcerative Colitis.

J Crohns Colitis 2019 Jan 29. Epub 2019 Jan 29.

INSERM U954 and Department of Hepato-Gastroenterology, University Hospital of Nancy, Lorraine University, Vandoeuvre-lès-Nancy, France.

View Article

Download full-text PDF

Source
https://academic.oup.com/ecco-jcc/advance-article/doi/10.109
Publisher Site
http://dx.doi.org/10.1093/ecco-jcc/jjz029DOI Listing
January 2019

Meta-Analysis of the Association Between Anti-Tumour Necrosis Factor Use and Lymphoma Risk in Patients With Inflammatory Bowel Disease: Methodological Considerations.

J Crohns Colitis 2018 Nov;12(10):1257-1258

Department of Biomedical Sciences, Humanitas University, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ecco-jcc/jjy094DOI Listing
November 2018

Systematic screening for primary sclerosing cholangitis with magnetic resonance cholangiography in inflammatory bowel disease.

Dig Liver Dis 2018 10 31;50(10):1012-1018. Epub 2018 Jul 31.

Department of Gastroenterology, Nancy University Hospital, Lorraine University, Vandœuvre-lès-Nancy, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.dld.2018.06.024DOI Listing
October 2018

Clinical efficacy of the Toll-like receptor 9 agonist cobitolimod using patient-reported-outcomes defined clinical endpoints in patients with ulcerative colitis.

Dig Liver Dis 2018 10 22;50(10):1019-1029. Epub 2018 Jun 22.

Nottingham Digestive Diseases Centre, Department of Gastroenterology, Nottingham University Hospitals, Nottingham, United Kingdom. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.dld.2018.06.010DOI Listing
October 2018

Treatment Persistence of Infliximab Versus Adalimumab in Ulcerative Colitis: A 16-Year Single-Center Experience.

Inflamm Bowel Dis 2018 Oct 16. Epub 2018 Oct 16.

INSERM U954 and Department of Hepatogastroenterology, Nancy University Hospital, Université de Lorraine, Vandoeuvre-lès-Nancy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ibd/izy322DOI Listing
October 2018

Heterogeneity in Definitions of Efficacy and Safety Endpoints for Clinical Trials of Crohn's Disease: A Systematic Review.

Clin Gastroenterol Hepatol 2018 Sep 27;16(9):1407-1419.e22. Epub 2018 Mar 27.

Robarts Clinical Trials, Western University, London, Ontario, Canada; Department of Medicine, Western University, London, Ontario, Canada; Department of Epidemiology and Biostatistics, Western University, London, Ontario, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2018.02.051DOI Listing
September 2018

Positioning Tofacitinib in the Treatment Algorithm of Moderate to Severe Ulcerative Colitis.

Inflamm Bowel Dis 2018 09;24(10):2106-2112

Department of Hepato-Gastroenterology and Inserm U954, University Hospital of Nancy, University of Lorraine, Vandoeuvre-lès-Nancy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ibd/izy076DOI Listing
September 2018

Impact of age at diagnosis on natural history of patients with elderly-onset ulcerative colitis: A French population-based study.

Dig Liver Dis 2018 Sep 22;50(9):903-909. Epub 2018 Apr 22.

Public Health, Epidemiology and Economic Health, Epimad Registry, Hospital & University Centre of Clinical Research, Lille University and Hospital, France; Lille Inflammation Research International Center LIRIC-UMR 995 Inserm Lille 2 University, CHRU de Lille, Lille, France. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15908658183070
Publisher Site
http://dx.doi.org/10.1016/j.dld.2018.04.011DOI Listing
September 2018

Colorectal cancer prevention in patients with ulcerative colitis.

Best Pract Res Clin Gastroenterol 2018 Feb - Apr;32-33:103-109. Epub 2018 May 16.

Department of Gastroenterology and NGERE Unit, Inserm, University Hospital of Nancy, Lorraine University, Vandoeuvre-lès-Nancy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bpg.2018.05.010DOI Listing
September 2018

Should we use anti-tumor necrosis factor agents or vedolizumab as first-line biological therapy in ulcerative colitis?

Best Pract Res Clin Gastroenterol 2018 Feb - Apr;32-33:17-25. Epub 2018 May 12.

Department of Gastroenterology, Nancy University Hospital, Université de Lorraine, 1 Allée du Morvan, 54511, Vandoeuvre-lès-Nancy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bpg.2018.05.006DOI Listing
September 2018

Safety of biological therapies in ulcerative colitis: An umbrella review of meta-analyses.

Best Pract Res Clin Gastroenterol 2018 Feb - Apr;32-33:43-47. Epub 2018 Jun 11.

Department of Biomedical Sciences, Humanitas University, 20090, Pieve Emanuele, Milan, Italy; IBD Center, Humanitas Clinical and Research Center, 20089, Rozzano, Milan, Italy. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15216918183000
Publisher Site
http://dx.doi.org/10.1016/j.bpg.2018.05.005DOI Listing
September 2018

Review article: treating-to-target for inflammatory bowel disease-associated anaemia.

Aliment Pharmacol Ther 2018 Sep 1;48(6):610-617. Epub 2018 Aug 1.

IBD Center and Department of Biomedical Sciences, Humanitas Clinical and Research Center, Humanitas University, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/apt.14922DOI Listing
September 2018

The nocebo effect: a clinical challenge in the era of biosimilars.

Expert Rev Clin Immunol 2018 09 30;14(9):739-749. Epub 2018 Aug 30.

a Department of Gastroenterology , Nancy University Hospital , Vandœuvre-lès-Nancy , France.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/1744666X.2018.1
Publisher Site
http://dx.doi.org/10.1080/1744666X.2018.1512406DOI Listing
September 2018

Metagenomic analysis of intestinal mucosa revealed a specific eukaryotic gut virome signature in early-diagnosed inflammatory bowel disease.

Gut Microbes 2019 25;10(2):149-158. Epub 2018 Sep 25.

a IBD Center, Laboratory of Gastrointestinal Immunopathology , Humanitas Clinical and Research Center , Milan , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/19490976.2018.1511664DOI Listing
September 2018

Quality of Care in Ulcerative Colitis: A Modified Delphi Panel Approach.

Dig Dis 2018 3;36(5):346-353. Epub 2018 Jul 3.

Center for Observational and Real-World Evidence (CORE), Merck & Co., Inc., Kenilworth, New Jersey, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000489845DOI Listing
August 2018

Evolving strategies and goals of treatment in ulcerative colitis.

Best Pract Res Clin Gastroenterol 2018 Feb - Apr;32-33:1-2

IBD Centre, Humanitas Clinical and Research Centre, Rozzano, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Rozzano, Milan, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bpg.2018.07.001DOI Listing
August 2018

Identification of Endpoints for Development of Antifibrosis Drugs for Treatment of Crohn's Disease.

Gastroenterology 2018 07 28;155(1):76-87. Epub 2018 Mar 28.

Department of Hepato-Gastroenterology and Inserm U954, University Hospital of Nancy, University of Lorraine, Vandoeuvre-lès-Nancy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2018.03.032DOI Listing
July 2018

PF-00547659 for the treatment of Crohn's disease and ulcerative colitis.

Expert Opin Investig Drugs 2018 Jul 16;27(7):623-629. Epub 2018 Jul 16.

a IBD Centre, Humanitas Clinical and Research Centre , Milan , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/13543784.2018.1494722DOI Listing
July 2018

High Risk of Anal and Rectal Cancer in Patients With Anal and/or Perianal Crohn's Disease.

Clin Gastroenterol Hepatol 2018 Jun 2;16(6):892-899.e2. Epub 2017 Dec 2.

Department of Pathology, AP-HP, Hôpital Saint-Antoine, Sorbonne Université, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2017.11.041DOI Listing
June 2018

Pneumococcal and influenza vaccine uptake in adults with inflammatory bowel disease in France: Results from a web-based study.

Dig Liver Dis 2018 Jun 2;50(6):563-567. Epub 2018 Jan 2.

Inserm, F-CRIN, Innovative Clinical Research Network in Vaccinology (I-REIVAC), Paris, France; Inserm, CIC 1417, Paris, France; Paris Descartes University, Sorbonne Paris Cité, Paris, France; AP-HP, Cochin Hospital, CIC Cochin Pasteur, Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.dld.2017.12.027DOI Listing
June 2018

Infliximab biosimilar CT-P13 for inflammatory bowel disease.

Lancet Gastroenterol Hepatol 2018 06 30;3(6):373-375. Epub 2018 Mar 30.

Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele 20090, Milan, Italy; IBD Center, Humanitas Clinical and Research Center, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2468-1253(18)30116-XDOI Listing
June 2018

Diffusion-weighted MRI in inflammatory bowel disease.

Lancet Gastroenterol Hepatol 2018 06;3(6):433-443

Department of Gastroenterology, Nancy University Hospital, Université de Lorraine, Nancy, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2468-1253(18)30054-2DOI Listing
June 2018

Heterogeneity in Definitions of Endpoints for Clinical Trials of Ulcerative Colitis: A Systematic Review for Development of a Core Outcome Set.

Clin Gastroenterol Hepatol 2018 May 24;16(5):637-647.e13. Epub 2017 Aug 24.

Robarts Clinical Trials, Western University, London, Ontario, Canada; Department of Medicine, Western University, London, Ontario, Canada; Department of Epidemiology and Biostatistics, Western University, London, Ontario, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2017.08.025DOI Listing
May 2018

Zinc-Alpha-2-Glycoprotein in Inflammatory Bowel Disease.

Inflamm Bowel Dis 2018 04;24(5):e10

IMoPA, UMR7365 CNRS-Université de Lorraine, Vandœuvre Les Nancy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ibd/izy120DOI Listing
April 2018

Is the Pharmacokinetic Profile of a First Anti-TNF Predictive of the Clinical Outcome and Pharmacokinetics of a Second Anti-TNF?

Inflamm Bowel Dis 2018 Apr 26. Epub 2018 Apr 26.

Department of Gastroenterology, Hospices Civils de Lyon, University Claude Bernard Lyon and INSERM, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ibd/izy111DOI Listing
April 2018

Prolonged azathioprine treatment reduces the need for surgery in early Crohn's disease.

J Gastroenterol Hepatol 2018 Mar;33(3):664-670

Department of Gastroenterology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jgh.14000DOI Listing
March 2018

It is Time to Revise the STRIDE Guidelines Determining Therapeutic Goals for Treat-to-Target in Inflammatory Bowel Disease.

J Crohns Colitis 2018 Mar;12(4):509

Department of Gastroenterology, Nancy University Hospital, Université de Lorraine, Nancy 1, Allée du Morvan, Vandœuvre-lès-Nancy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ecco-jcc/jjx174DOI Listing
March 2018

Sexual and reproductive issues and inflammatory bowel disease: a neglected topic in men.

Eur J Gastroenterol Hepatol 2018 Mar;30(3):316-322

IBD Centre, Humanitas Clinical and Research Centre.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MEG.0000000000001074DOI Listing
March 2018

Telehealth in Inflammatory Bowel Disease: Every Patient May Need a Coach!

Gastroenterology 2018 Mar 31;154(4):1196-1198. Epub 2018 Jan 31.

Department of Hepato-Gastroenterology and Inserm U954, University Hospital of Nancy, Lorraine University, Vandoeuvre-lès-Nancy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2018.01.036DOI Listing
March 2018

Vedolizumab for the treatment of Crohn's disease.

Expert Rev Clin Immunol 2018 03 23;14(3):179-189. Epub 2018 Feb 23.

b IBD Center, Department of Gastroenterology , Humanitas Research Hospital , Milan , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/1744666X.2018.1438189DOI Listing
March 2018

Dramatic Increase in Incidence of Ulcerative Colitis and Crohn's Disease (1988-2011): A Population-Based Study of French Adolescents.

Authors:
Silvia Ghione Hélène Sarter Mathurin Fumery Laura Armengol-Debeir Guillaume Savoye Delphine Ley Claire Spyckerelle Benjamin Pariente Laurent Peyrin-Biroulet Dominique Turck Corinne Gower-Rousseau J M Andre M Antonietti A Aouakli A Armand I Aroichane F Assi J P Aubet E Auxenfants F Ayafi-Ramelot D Bankovski B Barbry N Bardoux P Baron A Baudet B Bazin A Bebahani J P Becqwort V Benet H Benali C Benguigui Ben E Soussan A Bental I Berkelmans J Bernet K Bernou C Bernou-Dron P Bertot N Bertiaux-Vandaële V Bertrand E Billoud N Biron B Bismuth M Bleuet F Blondel V Blondin P Bohon E Boniface P Bonnière E Bonvarlet P Bonvarlet A Boruchowicz R Bostvironnois M Boualit B Bouche C Boudaillez C Bourgeaux M Bourgeois A Bourguet A Bourienne J Branche G Bray F Brazier P Breban H Brihier V Brung-Lefebvre P Bulois P Burgiere J Butel J Y Canva V Canva-Delcambre J P Capron F Cardot P Carpentier E Cartier J F Cassar M Cassagnou J F Castex P Catala S Cattan S Catteau B Caujolle G Cayron C Chandelier M Chantre J Charles T Charneau M Chavance-Thelu D Chirita A Choteau J F Claerbout P Y Clergue H Coevoet G Cohen R Collet J F Colombel S Coopman J Corvisart A Cortot F Couttenier J F Crinquette V Crombe I Dadamessi V Dapvril T Davion S Dautreme J Debas N Degrave F Dehont C Delatre R Delcenserie O Delette T Delgrange L Delhoustal J S Delmotte S Demmane G Deregnaucourt P Descombes J P Desechalliers P Desmet P Desreumaux G Desseaux P Desurmont A Devienne E Devouge M Devred A Devroux A Dewailly S Dharancy A Di Fiore D Djeddi R Djedir M L Dreher-Duwat R Dubois C Dubuque P Ducatillon J Duclay B Ducrocq F Ducrot P Ducrotte A Dufilho C Duhamel D Dujardin C Dumant-Forest J L Dupas F Dupont Y Duranton A Duriez K El Achkar M El Farisi C Elie M C Elie-Legrand A Elkhaki M Eoche D Evrard J P Evrard A Fatome B Filoche L Finet M Flahaut C Flamme D Foissey P Fournier M C Foutrein-Comes P Foutrein D Fremond T Frere M Fumery P Gallet C Gamblin P S Ganga-Zandzou R Gérard G Geslin Y Gheyssens N Ghossini S Ghrib T Gilbert B Gillet D Godard P Godard J M Godchaux R Godchaux G Goegebeur O Goria F Gottrand P Gower B Grandmaison M Groux C Guedon J F Guillard L Guillem F Guillemot D Guimber B Haddouche S Hakim D Hanon V Hautefeuille P Heckestweiller G Hecquet J P Hedde H Hellal P E Henneresse B Heyman M Heraud S Herve P Hochain L Houssin-Bailly P Houcke B Huguenin S Iobagiu A Ivanovic I Iwanicki-Caron E Janicki M Jarry J Jeu J P Joly C Jonas F Katherin A Kerleveo A Khachfe A Kiriakos J Kiriakos O Klein M Kohut R Kornhauser D Koutsomanis J E Laberenne G Laffineur M Lagarde P Lannoy J Lapchin M Lapprand D Laude R Leblanc P Lecieux N Leclerc C Le Couteulx J Ledent J Lefebvre P Lefiliatre C Legrand A Le Grix P Lelong B Leluyer C Lenaerts L Lepileur A Leplat E Lepoutre-Dujardin H Leroi M Y Leroy J P Lesage X Lesage J Lesage I Lescanne-Darchis J Lescut D Lescut B Leurent P Levy M Lhermie A Lion B Lisambert F Loire S Louf A Louvet M Luciani D Lucidarme J Lugand O Macaigne D Maetz D Maillard H Mancheron O Manolache A B Marks-Brunel R Marti F Martin G Martin E Marzloff P Mathurin J Mauillon V Maunoury J L Maupas B Mesnard P Metayer L Methari B Meurisse F Meurisse L Michaud X Mirmaran P Modaine A Monthe L Morel P E Mortier E Moulin O Mouterde J Mudry M Nachury NʼGuyen E Khac B Notteghem V Ollevier A Ostyn A Ouraghi D Ouvry B Paillot N Panien-Claudot C Paoletti A Papazian B Parent B Pariente J C Paris P Patrier L Paupart B Pauwels M Pauwels R Petit M Piat S Piotte C Plane B Plouvier E Pollet P Pommelet D Pop C Pordes G Pouchain P Prades A Prevost J C Prevost B Quesnel A M Queuniet J F Quinton A Rabache P Rabelle G Raclot S Ratajczyk D Rault V Razemon N Reix M Revillon C Richez P Robinson J Rodriguez J Roger J M Roux A Rudelli A Saber G Savoye P Schlosseberg M Segrestin D Seguy M Serin A Seryer F Sevenet N Shekh J Silvie V Simon C Spyckerelle N Talbodec A Techy J L Thelu A Thevenin H Thiebault J Thomas J M Thorel G Tielman M Tode J Toisin J Tonnel J Y Touchais Y Touze J L Tranvouez C Triplet D Turck S Uhlen E Vaillant C Valmage D Vanco H Vandamme E Vanderbecq Vander E Eecken P Vandermolen P Vandevenne L Vandeville A Vandewalle C Vandewalle P Vaneslander J P Vanhoove A Vanrenterghem P Varlet I Vasies G Verbiese G Vernier-Massouille P Vermelle C Verne P Vezilier-Cocq B Vigneron M Vincendet J Viot Y M Voiment A Wacrenier L Waeghemaecker J Y Wallez M Wantiez F Wartel J Weber J L Willocquet N Wizla E Wolschies A Zalar B Zaouri A Zellweger C Ziade

Am J Gastroenterol 2018 Feb 15;113(2):265-272. Epub 2017 Aug 15.

Public Health, Epidemiology and Economic Health, Epimad registry, Regional house of clinical research, Lille Hospital and University, Lille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ajg.2017.228DOI Listing
February 2018

Novel therapeutic targets for inflammatory bowel disease.

J Autoimmun 2017 Dec 12;85:103-116. Epub 2017 Jul 12.

IBD Center, Department of Gastroenterology, Humanitas Research Hospital, Rozzano, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Rozzano, Milan, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaut.2017.07.004DOI Listing
December 2017

Early intervention in Crohn's disease: towards disease modification trials.

Gut 2017 12 5;66(12):2179-2187. Epub 2017 Sep 5.

Department of Hepato-Gastroenterology and Inserm U954, University Hospital of Nancy, Lorraine University, Vandoeuvre-lès-Nancy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/gutjnl-2017-314519DOI Listing
December 2017

Management of patients with inflammatory bowel disease and spondyloarthritis.

Expert Rev Clin Pharmacol 2017 Dec 20;10(12):1363-1374. Epub 2017 Sep 20.

g Inserm U954 and Department of Gastroenterology , Nancy University Hospital, Université de Lorraine , Vandœuvre-lès-Nancy , France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17512433.2017.1377609DOI Listing
December 2017

E-health in inflammatory bowel diseases: More challenges than opportunities?

Dig Liver Dis 2017 Dec 24;49(12):1320-1326. Epub 2017 Aug 24.

Inserm U954 and Department of Gastroenterology, Nancy University Hospital, University of Lorraine, Vandoeuvre-lès-Nancy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.dld.2017.08.026DOI Listing
December 2017

Microbiota in digestive cancers: our new partner?

Carcinogenesis 2017 12;38(12):1157-1166

Department of Gastroenterology and Hepatology and Inserm U954, Nancy University Hospital, Lorraine University, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/carcin/bgx087DOI Listing
December 2017

Keeping the (S)toolbox Alive Outside of the Body for Drugs Discovery.

Gastroenterology 2017 Dec 31;153(6):1689-1691. Epub 2017 Oct 31.

University of Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille and Center for Infection and Immunity of Lille, Lille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2017.10.022DOI Listing
December 2017

MFSD2A Promotes Endothelial Generation of Inflammation-Resolving Lipid Mediators and Reduces Colitis in Mice.

Gastroenterology 2017 11 4;153(5):1363-1377.e6. Epub 2017 Aug 4.

IBD Center, Laboratory of Gastrointestinal Immunopathology, Humanitas Clinical and Research Center, Rozzano, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Rozzano, Milan, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2017.07.048DOI Listing
November 2017

Distinct Thresholds of Infliximab Trough Level Are Associated with Different Therapeutic Outcomes in Patients with Inflammatory Bowel Disease: A Prospective Observational Study.

Inflamm Bowel Dis 2017 11;23(11):2048-2053

*Department of Gastroenterology, University Hospital of Saint Etienne, Saint Etienne, France; †Department of Gastroenterology, Hospices Civils de Lyon, and INSERM U1111, Lyon, France; ‡Department of Statistics, University of Lyon, Lyon, France; §Department of Gastroenterology, University Hospital of Nancy, Nancy, France; and ‖Department of Immunology, CIC1408, GIMAP EA3064, University Hospital of Saint Etienne, Saint Etienne, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MIB.0000000000001223DOI Listing
November 2017

Preventing disability in inflammatory bowel disease.

Therap Adv Gastroenterol 2017 Nov 16;10(11):865-876. Epub 2017 Oct 16.

INSERM U954 and Department of Hepatogastroenterology, Nancy University Hospital, Lorraine University, Allée du Morvan, F-54511 Vandoeuvre-lès-Nancy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1756283X17732720DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5673018PMC
November 2017

Infection Risk With Biologic Therapy in Patients With Inflammatory Bowel Disease.

Clin Pharmacol Ther 2017 Oct 16;102(4):633-641. Epub 2017 Aug 16.

Department of Gastroenterology, IBD Center, Humanitas Clinical and Research Center, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cpt.791DOI Listing
October 2017

Indicators of suboptimal tumor necrosis factor antagonist therapy in inflammatory bowel disease.

Dig Liver Dis 2017 Oct 1;49(10):1086-1091. Epub 2017 Aug 1.

Takeda Development Centre Europe Ltd., London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.dld.2017.07.010DOI Listing
October 2017

Adherence to infliximab therapy in inflammatory bowel disease patients in a real-life setting.

J Dig Dis 2017 Oct;18(10):566-573

Inserm U954 and Department of Gastroenterology, University Hospital of Nancy, Lorraine University, Vandoeuvre-lès-Nancy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/1751-2980.12539DOI Listing
October 2017

IBD: To switch or not to switch: that is the biosimilar question.

Nat Rev Gastroenterol Hepatol 2017 Sep 5;14(9):508-509. Epub 2017 Jul 5.

Department of Hepato-Gastroenterology and Inserm U954, University Hospital of Nancy, Lorraine University, Vandoeuvre-lès-Nancy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrgastro.2017.86DOI Listing
September 2017

Tofacitinib Is the Right OCTAVE for Ulcerative Colitis.

Gastroenterology 2017 Sep 27;153(3):862-864. Epub 2017 Jul 27.

Department of Hepato-Gastroenterology and Inserm U954, University Hospital of Nancy, Lorraine University, Vandoeuvre-lès-Nancy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2017.07.027DOI Listing
September 2017

Filgotinib in Crohn's Disease: JAK Is Back.

Gastroenterology 2017 Aug 24;153(2):603-605. Epub 2017 Jun 24.

Department of Hepato-Gastroenterology and Inserm U954, University Hospital of Nancy, Lorraine University, Vandoeuvre-lès-Nancy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2017.06.040DOI Listing
August 2017